Table 2.
ID No. | Podocytes |
GBM |
Endothelium |
Mesangium |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FP Effacement | FP Irreg. | FP Actin Condens. | μ-Villi | Vacuoles | ED AGG | GRAN | Thickening | Irreg. | DC | Subepi. EDD | Subendo. EDD | Swelling | Loss of Fenestrae | Matrix Expan. | Cellular Expan. | EDD | |
FSA-1622 | 2+ | 2+ | 1+ | 2+ | 2+ | 1+ | 0 | 1+ | 1+ | 0 | 0 | 0 | 1+ | 1+ | 1+ | 1+ | 1+ |
FGCI-1111 | 2+ | 2+ | 2+ | 1+ | 3+ | 3+ | 0 | 0 | 1+ | 1+ | 1+ | 1+ | 1+ | 1+ | 1+ | 1+ | 2+ |
FSA-192 | 2+ | 2+ | 2+ | 2+ | 1+ | 1+ | 0 | 2+ | 1+ | 1+ | 0 | 0 | 1+ | 1+ | 2+ | 2+ | 1+ |
FGCI-111 | 3+ | 1+ | 3+ | 2+ | 2+ | 3+ | 2+ | 0 | 1+ | 1+ | 0 | 0 | 1+ | 1+ | 1+ | 1+ | 1+ |
FGCI-1112 | 3+ | 2+ | 2+ | 3+ | 2+ | 2+ | 0 | 1+ | 1+ | 2+ | 0 | 2+ | 2+ | 2+ | 1+ | 1+ | 1+ |
1FSGS-1 | 3+ | 3+ | 2+ | 3+ | 2+ | 0 | 0 | 1+ | 1+ | 2+ | 0 | 1+ | 2+ | 2+ | 3+b | 3+b | 0 |
1FSGS-2 | 3+ | 3+ | 2+ | 2+ | 1+ | 0 | 0 | 0 | 0 | 1+ | 0 | 0 | 1+ | 1+ | 2+ | 2+ | 0 |
1FSGS-3 | 2+ | 3+ | 1+ | 2+ | 2+ | 0 | 0 | 0 | 1+ | 1+ | 0 | 1+ | 1+ | 1+ | 2+ | 2+ | 2+ |
1FSGS-4 | 4+ | 4+ | 3+ | 3+ | 1+ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1+ | 1+ | 0 |
2FSGS-1 | 1+ | 2+ | 2+ | 1+ | 0 | 0 | 0 | 0 | 0 | 1+ | 0 | 0 | 1+ | 1+ | 2+ | 2+ | 1+ |
2FSGS-2 | 1+ | 1+ | 1+ | 1+ | 1+ | 0 | 0 | 0 | 1+ | 1+ | 0 | 0 | 1+ | 1+ | 1+ | 1+ | 0 |
2FSGS-3 | 1+ | 1+ | 1+ | 1+ | 1+ | 0 | 0 | 1+ | 0 | 1+ | 0 | 0 | 2+ | 2+ | 1+ | 2+ | 0 |
2FSGS-4 | 2+ | 1+ | 1+ | 2+ | 2+ | 0 | 0 | 1+ | 2+ | 1+ | 0 | 0 | 2+ | 2+ | 2+ | 1+ | 0 |
All findings graded on a scale of 0 (no involvement) to 4+ (severe involvement). 1FSGS, primary FSGS; 2FSGS, postadaptive FSGS; FP, foot process; ED AGG, electron-dense intracytoplasmic aggregates; GRAN, intracytoplasmic electron-dense lysosomes (reabsorption granules); DC, double contours; EDD, electron-dense deposits.
No history of diabetes in this patient.